封面
市場調查報告書
商品編碼
1629213

GMP 細胞銀行服務市場,按細胞類型、應用、最終用戶、國家和地區 - 2025-2032 年全球產業分析、市場規模、市場佔有率和預測

GMP Cell Banking Services Market, By Cell Type, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 395 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2024 年 GMP 細胞銀行服務市場規模為 8.5623 億美元,2025 年至 2032 年複合年成長率為 13.7%。

Gmp 細胞銀行服務市場-市場動態

對生物製藥的需求不斷成長推動 GMP 細胞銀行服務市場的成長

由於對生物製藥的需求不斷成長,GMP(良好生產規範)細胞銀行服務市場正在經歷顯著成長。隨著全球生物製藥產業的擴張,特別是在基因療法、細胞療法和再生醫學領域,對高品質、合規細胞庫的需求激增。據美國食品和藥物管理局 (FDA) 稱,目前有超過 1,000 種細胞和基因治療產品正在研究或已獲得批准。此外,個人化醫療的進步,近年來批准的 20 多種細胞療法,也促進了該市場的成長。擴大採用基於細胞的療法,特別是針對癌症和遺傳性疾病,推動了對符合 GMP 設施的需求,以確保監管標準和產品品質。然而,市場面臨營運成本高、監管要求嚴格等挑戰。儘管存在這些挑戰,但擴大 GMP 細胞庫能力仍存在機遇,特別是在亞太地區等新興市場,這些市場對生物技術研發的投資正在增加。

Gmp 細胞銀行服務市場 - 關鍵見解

根據我們的研究分析師分享的分析,預計全球市場在預測期內(2025-2032 年)每年將以 13.7% 左右的複合年成長率成長

根據細胞類型細分,預計哺乳動物細胞將在 2024 年顯示最大的市場佔有率

從應用細分來看,生物製藥公司是2024年領先的應用

按地區分類,北美是 2024 年的主要收入來源

Gmp 細胞銀行服務市場-細分分析:

全球 GMP 細胞銀行服務市場根據細胞類型、應用、最終用戶和地區進行細分。

根據細胞類型,市場分為六類:哺乳動物、微生物、昆蟲、酵母、禽類和幹細胞。哺乳動物細胞由於在生物製藥生產中廣泛使用而具有最高優先順序。在再生醫學進步的推動下,幹細胞緊隨其後。微生物、酵母、昆蟲、鳥類和其他細胞類型是具有不同應用的進一步細分。

根據應用市場分為兩類:生物製藥公司和合約製造組織。由於藥物開發和生產對細胞系的高需求,生物製藥公司處於領先地位。合約製造組織 (CMO) 緊隨其後,成為製藥業外包細胞銀行服務的主要合作夥伴。

Gmp 細胞銀行服務市場 - 地理洞察

GMP 細胞銀行服務市場呈現出顯著的地理差異,其中北美領先市場,這主要是由主要製藥公司的存在、先進的醫療基礎設施和嚴格的監管標準推動的。尤其是美國,由於其強大的生物製藥業,在細胞和基因療法方面擁有大量投資,成為一個主要中心。歐洲市場緊隨其後,受益於歐洲藥品管理局 (EMA) 等既定監管框架,該框架確保細胞銀行服務的高品質標準。此外,歐盟一直積極推動生物技術創新,為GMP細胞銀行服務提供了良好的環境。在亞太地區,在生物技術研究和製造投資增加的推動下,市場正在顯著成長。在政府措施以及對生物製劑和再生藥物不斷成長的需求的支持下,中國、日本和印度等國家正在成為關鍵參與者。對開發個人化醫療和增加臨床試驗活動的日益關注也推動了該地區的市場擴張。

Gmp 細胞銀行服務市場-競爭格局:

GMP 細胞銀行服務市場競爭激烈,多家知名企業提供廣泛的服務。主要市場參與者包括 Lonza Group、Charles River Laboratories、WuXi AppTec 和 Merck KGaA 等。這些公司因其在細胞株開發、冷凍保存和符合良好生產規範 (GMP) 標準的監管合規性方面的強大能力而受到認可。龍沙集團尤其具有影響力,提供從細胞銀行到最終產品製造的全面服務,在北美和歐洲擁有強大的影響力。 Charles River Laboratories 是另一個關鍵參與者,提供合約研究和細胞銀行服務,專注於加速細胞和基因療法的開發。藥明康德透過為細胞療法開發提供端到端解決方案來滿足全球客戶群的需求,從而鞏固了其地位。 Merck KGaA 是一個重要的競爭對手,以其在細胞培養、基因編輯和細胞檢測服務方面的專業知識而聞名。隨著市場的擴大,這些公司繼續投資於先進技術和策略合作夥伴關係,以增強其產品並滿足對生物製藥日益成長的需求。

最新進展:

2024 年 5 月,REPROCELL 擴大了其 GMP 級幹細胞主細胞庫服務,現在提供用於治療應用的人類誘導多能性細胞 (hiPSC)。新的 Cytocentric Xvivo 系統增強了細胞培養的一致性,降低了污染風險,並加速了 GMP 產品生產。

2019 年 8 月,賽多利斯推出了哺乳動物細胞庫製造的新服務,增強了其 GMP 合規能力。這些服務簡化了生產流程,確保為生物製藥應用提供高品質的細胞庫,從而支援客戶加快開發進度並提高監管合規性。

目錄

第 1 章:GMP 細胞銀行服務市場概述

  • 研究範圍
  • 市場預估年份

第 2 章:執行摘要

  • 市場片段
    • 按細胞類型分類的 Gmp 細胞銀行服務市場片段
    • 按應用分類的 Gmp 細胞銀行服務市場片段
    • 最終用戶的 Gmp 細胞銀行服務市場片段
    • 按國家/地區分類的 Gmp 細胞銀行服務市場片段
    • 按地區分類的 Gmp 細胞銀行服務市場片段
  • 競爭洞察

第 3 章:GMP 細胞銀行服務主要市場趨勢

  • Gmp 細胞銀行服務市場促進因素
    • 市場促進因素的影響分析
  • Gmp 細胞銀行服務市場限制
    • 市場限制影響分析
  • Gmp 細胞銀行服務市場機會
  • Gmp 細胞銀行服務市場未來趨勢

第 4 章:GMP 細胞銀行服務業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章:GMP 細胞銀行服務市場:地緣政治緊張局勢升級的影響

  • COVID-19 大流行的影響
  • 俄羅斯-烏克蘭戰爭的影響
  • 中東衝突的影響

第 6 章:GMP 細胞銀行服務市場格局

  • 2024 年 Gmp 細胞銀行服務市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章:GMP 細胞銀行服務市場 - 按細胞類型

  • 概述
    • 按電池類型分類的細分市場佔有率分析
    • 哺乳動物
    • 微生物
    • 昆蟲
    • 酵母菌
    • 禽類
    • 幹細胞
    • 其他

第 8 章:GMP 細胞銀行服務市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 生物製藥公司
    • 合約製造組織

第 9 章:GMP 細胞銀行服務市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 製藥與生物技術
    • 醫療保健與生命科學
    • 農業與食品工業
    • 其他

第 10 章:GMP 細胞銀行服務市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • Gmp 細胞銀行服務北美主要製造商
    • 北美市場規模和預測(按國家)
    • 北美市場規模和預測(按電池類型)
    • 北美市場規模和預測(按應用)
    • 北美市場規模和預測(按最終用戶)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • Gmp 細胞銀行服務歐洲主要製造商
    • 歐洲市場規模和預測(按國家)
    • 歐洲市場規模和預測(按電池類型)
    • 歐洲市場規模和預測(按應用)
    • 歐洲市場規模和預測(按最終用戶)
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • Gmp 細胞銀行服務亞太地區主要製造商
    • 亞太地區市場規模與預測(按國家)
    • 亞太地區市場規模和預測(按電池類型)
    • 亞太地區市場規模與預測(按應用)
    • 按最終用戶分類的亞太地區市場規模和預測
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲 (LATAM)
    • 概述
    • Gmp 細胞銀行服務拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測(按國家)
    • 拉丁美洲市場規模和預測(按電池類型)
    • 拉丁美洲市場規模與預測(按應用)
    • 拉丁美洲市場規模和預測(按最終用戶)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲 (MEA)
    • 概述
    • Gmp 細胞銀行服務中東和非洲的主要製造商
    • MEA 市場規模和預測(按國家/地區)
    • MEA 市場規模和預測(按電池類型)
    • MEA 市場規模和預測(按應用)
    • MEA 市場規模和預測(按最終用戶)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章:主要供應商分析 - Gmp 細胞銀行服務業

  • 競爭儀表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Austrianova
    • BioReliance
    • BSL Bioservice
    • Charles River Laboratories
    • Cleancells
    • Covance
    • Eurofins Scientific
    • Goodwin Biotechnology
    • Lonza
    • Merck KGaA
    • Paragon Bioservices
    • Sartorius
    • SGS Life Sciences Ltd.
    • Thermo Fisher Scientific
    • ViruSure
    • WuXi AppTec
    • Others

第 12 章:360 度分析師視角

第 13 章:附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4580

REPORT HIGHLIGHT

GMP Cell Banking Services Market size was valued at US$ 856.23 Million in 2024, expanding at a CAGR of 13.7% from 2025 to 2032.

The GMP (Good Manufacturing Practice) Cell Banking Services Market focuses on the production and storage of cell lines under strictly regulated conditions to support research and biopharmaceutical manufacturing. With the growing demand for biopharmaceuticals, these services ensure high-quality, compliant cell lines for therapeutic production. Increasing applications in regenerative medicine, cell therapies, and vaccine development have expanded the market. However, challenges such as high costs and regulatory complexity may limit growth. For example, in 2020, the global regenerative medicine market was valued at $5.4 billion, pushing demand for GMP cell banking services. Opportunities lie in the growth of personalized medicine, the development of novel biotherapeutics, and expanding regulatory frameworks supporting cell-based treatments. With advancements in cryopreservation technologies and increasing industry collaboration, the market is set to experience continuous growth.

Gmp Cell Banking Services Market- Market Dynamics

Rising Demand for Biopharmaceuticals Drives Growth in the GMP Cell Banking Services Market

The GMP (Good Manufacturing Practice) Cell Banking Services Market is experiencing significant growth due to the rising demand for biopharmaceuticals. As the global biopharmaceutical sector expands, especially in gene therapies, cell-based therapies, and regenerative medicine, the need for high-quality, compliant cell banks has surged. According to the U.S. Food and Drug Administration (FDA), over 1,000 cell and gene therapy products are currently under investigation or have been approved. Furthermore, advancements in personalized medicine, with over 20 cell-based therapies approved in recent years, have contributed to this market's growth. The increasing adoption of cell-based therapeutics, especially for cancer and genetic disorders, is driving the need for GMP-compliant facilities to ensure regulatory standards and product quality. However, the market faces challenges such as high operational costs and stringent regulatory requirements. Despite these challenges, opportunities exist in expanding GMP cell banking capabilities, especially in emerging markets like Asia-Pacific, which are seeing increased investments in biotechnology research and development.

Gmp Cell Banking Services Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 13.7% over the forecast period (2025-2032)

Based on Cell Type segmentation, Mammalian Cells was predicted to show maximum market share in the year 2024

Based on application segmentation, Biopharmaceutical Companies was the leading application in 2024

Based on region, North America was the leading revenue generator in 2024

Gmp Cell Banking Services Market- Segmentation Analysis:

The Global GMP Cell Banking Services Market is segmented based on Cell Type, Application, End-User, and Region.

The market is divided into six categories based on Cell Type: Mammalian, Microbial, Insect, Yeast, Avian, and Stem Cell. Mammalian cells hold the highest priority due to their widespread use in biopharmaceutical production. Stem cells follow closely, driven by advances in regenerative medicine. Microbial, yeast, insect, avian, and other cell types are further segments with varying applications.

The market is divided into two categories based on application: Biopharmaceutical Companies and Contract Manufacturing Organizations. Biopharmaceutical companies lead due to the high demand for cell lines in drug development and production. Contract Manufacturing Organizations (CMOs) follow closely, serving as key partners for outsourced cell banking services in the pharmaceutical industry.

Gmp Cell Banking Services Market- Geographical Insights

The GMP Cell Banking Services Market shows notable geographical variation, with North America leading the market, primarily driven by the presence of key pharmaceutical companies, advanced healthcare infrastructure, and stringent regulatory standards. The United States, in particular, is a major hub due to its strong biopharmaceutical industry, with extensive investments in cell and gene therapies. The European market follows closely, benefiting from established regulatory frameworks, such as the European Medicines Agency (EMA), which ensures high-quality standards for cell banking services. Moreover, the European Union has been actively promoting biotechnology innovations, providing a favorable environment for GMP cell banking services. In the Asia-Pacific region, the market is witnessing significant growth, driven by increased investments in biotechnology research and manufacturing. Countries like China, Japan, and India are emerging as key players, supported by government initiatives and the growing demand for biologics and regenerative medicines. The growing focus on developing personalized medicine and increasing clinical trial activities are also propelling market expansion in the region.

Gmp Cell Banking Services Market- Competitive Landscape:

The GMP Cell Banking Services Market is highly competitive, with several prominent players offering a wide range of services. Key market participants include Lonza Group, Charles River Laboratories, WuXi AppTec, and Merck KGaA, among others. These companies are recognized for their strong capabilities in cell line development, cryopreservation, and regulatory compliance in line with Good Manufacturing Practice (GMP) standards. Lonza Group is particularly influential, providing comprehensive services from cell banking to final product manufacturing, with a strong presence in North America and Europe. Charles River Laboratories is another key player, offering contract research and cell banking services, focusing on accelerating cell and gene therapy development. WuXi AppTec has strengthened its position by offering end-to-end solutions for cell therapy development, catering to a global customer base. Merck KGaA is a significant competitor, known for its expertise in cell culture, gene editing, and cell-based assay services. As the market expands, these companies continue to invest in advanced technologies and strategic partnerships to enhance their offerings and cater to the increasing demand for biopharmaceuticals.

Recent Developments:

In May 2024, REPROCELL expanded its GMP-grade stem cell Master Cell Bank service, now offering Human Induced Pluripotent Cells (hiPSCs) for therapeutic applications. The new Cytocentric Xvivo system enhances cell culture consistency, reduces contamination risks, and accelerates GMP product production.

In August 2019, Sartorius launched new services for mammalian cell bank manufacture, enhancing its GMP-compliant capabilities. These services streamline the production process, ensuring high-quality cell banks for biopharmaceutical applications, thereby supporting clients in accelerating their development timelines and improving regulatory compliance.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GMP CELL BANKING SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Austrianova
  • BioReliance
  • BSL Bio service
  • Charles River Laboratories
  • Cleancells
  • Covance
  • Eurofins Scientific
  • Goodwin Biotechnology
  • Lonza
  • Merck KGaA
  • Paragon Bioservices
  • Sartorius
  • SGS Life Sciences Ltd.
  • Thermo Fisher Scientific
  • ViruSure
  • WuXi AppTec
  • Others

GLOBAL GMP CELL BANKING SERVICES MARKET, BY CELL TYPE- MARKET ANALYSIS, 2019 - 2032

  • Mammalian
  • Microbial
  • Insect
  • Yeast
  • Avian
  • Stem Cell
  • Others

GLOBAL GMP CELL BANKING SERVICES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations

GLOBAL GMP CELL BANKING SERVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceuticals & Biotechnology
  • Healthcare & Life Sciences
  • Agriculture & Food Industry
  • Others

GLOBAL GMP CELL BANKING SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Gmp Cell Banking Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Gmp Cell Banking Services Market Snippet by Cell Type
    • 2.1.2. Gmp Cell Banking Services Market Snippet by Application
    • 2.1.3. Gmp Cell Banking Services Market Snippet by End-User
    • 2.1.4. Gmp Cell Banking Services Market Snippet by Country
    • 2.1.5. Gmp Cell Banking Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Gmp Cell Banking Services Key Market Trends

  • 3.1. Gmp Cell Banking Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Gmp Cell Banking Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Gmp Cell Banking Services Market Opportunities
  • 3.4. Gmp Cell Banking Services Market Future Trends

4. Gmp Cell Banking Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Gmp Cell Banking Services Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Gmp Cell Banking Services Market Landscape

  • 6.1. Gmp Cell Banking Services Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Gmp Cell Banking Services Market - By Cell Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Cell Type, 2024 & 2032 (%)
    • 7.1.2. Mammalian
    • 7.1.3. Microbial
    • 7.1.4. Insect
    • 7.1.5. Yeast
    • 7.1.6. Avian
    • 7.1.7. Stem Cell
    • 7.1.8. Others

8. Gmp Cell Banking Services Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Biopharmaceutical Companies
    • 8.1.3. Contract Manufacturing Organizations

9. Gmp Cell Banking Services Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 9.1.2. Pharmaceuticals & Biotechnology
    • 9.1.3. Healthcare & Life Sciences
    • 9.1.4. Agriculture & Food Industry
    • 9.1.5. Others

10. Gmp Cell Banking Services Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Gmp Cell Banking Services Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Gmp Cell Banking Services Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Gmp Cell Banking Services Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Gmp Cell Banking Services Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Gmp Cell Banking Services Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Gmp Cell Banking Services Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Austrianova
    • 11.2.2. BioReliance
    • 11.2.3. BSL Bioservice
    • 11.2.4. Charles River Laboratories
    • 11.2.5. Cleancells
    • 11.2.6. Covance
    • 11.2.7. Eurofins Scientific
    • 11.2.8. Goodwin Biotechnology
    • 11.2.9. Lonza
    • 11.2.10. Merck KGaA
    • 11.2.11. Paragon Bioservices
    • 11.2.12. Sartorius
    • 11.2.13. SGS Life Sciences Ltd.
    • 11.2.14. Thermo Fisher Scientific
    • 11.2.15. ViruSure
    • 11.2.16. WuXi AppTec
    • 11.2.17. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us